BridgeBio


BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases.

Industries

Employees

201-500

Links


Org chart

Hiring!

Neil Kumar
CEO, Co-Founder & Director
Collapse
Barrett Katz
President & CMO
Eric David
CEO, Gene Therapy
Matt Outten
Chief Executive Officer At QED Therapeutics Oncology And Chief Commercial Officer At Bridgebio
Uma Sinha
Chief Scientific Officer
Adora Ndu
Chief Regulatory Affairs Officer
Thomas Trimarchi
President And Chief Financial Officer
Teja Reddi
Director, Business Development & Operations
Josh Loehrer
Chief People Officer
Julie Kron
Director, Program Management
Mary Rohrer
Director, Patient Recruitment & Retention at BridgeBio
Tina Knell
Senior Director, Revenue
Scott Collins
SVP & Head , Market Access
Riccardo Panicucci
Chief Technology Officer
Sharon Rudo
VP, Drug Safety
Thomas Gnielinski
VP, Law Commercial & Compliance
Julie Miller Everett
Chief Business Officer
Roberta Davis
Senior Executive Administrator To The CEO
Cameron Turtle
Chief Strategy Officer
Bubba Murarka
Executive Vice President
Shweta Rane
Executive Director
Ananth Sridhar
Chief Operating Officer (eidos Therapeutics & Calcilytix Therapeutics)

Board & advisors